Watching the monitors: "PAID" prescriptions, fiscal intermediaries and drug-utilization review.
Prescription monitoring evolved from the need of drug firms to obtain marketing information. Today, extensive monitoring is also done by fiscal intermediaries who administer prepaid drug benefit plans, both private and governmental, particularly Medicaid. The most important such agent is PAID Prescriptions. Under various contracts, PAID monitors physician, pharmacy, and patient behavior related to prescriptions and uses review processes that evaluate certain kinds of behavior for appropriateness. The criteria of appropriateness are essentially those that save money. PAID negotiates a program fee with the insurer (public or private) and applies constraints so that prescription and administrative costs do not overrun that fee. PAID and other monitors have contemplated expansion into the realm of defining and encouraging appropriate prescribing under the concept of "drugutilization review." The actual practices of PAID, particularly the background of fiscal enforcement, may impede the development of an actual drug-utilization review process.
D054598:Blue Cross Blue Shield Insurance Plans; D002140:California; D003201:Computers; D004347:Drug Interactions; D011307:Drug Prescriptions; D004363:Drug Utilization; D005252:Fees, Pharmaceutical; D006279:Health Maintenance Organizations; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008484:Medicaid; D008485:Medical Audit; D010361:Patients; D010595:Pharmacists; D010820:Physicians; D019966:Substance-Related Disorders; D014481:United States; D014600:Utilization Review